Treatment of Acute Myeloid Leukemia With Arsenic and All-trans Retinoid Acid

Inclusion Criteria: * Newly diagnosed or relapsed AML.Diagnosis based on Chinese guidelines for diagnosis and treatment of adult acute myeloid leukemia(not APL)(2018) * Older than 18 years old * Patients or their families signed written informed consent Exclusion Criteria: * Be allergic to the drug ingredient, the supplementary material or the allergic constitution person * Cardiac insufficiency, renal insufficiency, significant arrhythmias, EKG abnormalities or other important organ dysfunction * Combined with other malignant tumors * Pregnant and lactating women * Participants in other drug trials in the last 3 months * Suffering from mental illness or other circumstances which unable to carry out the plan * Other patients who were not suitable for the study